Canada-based LED Medical Diagnostics has announce that its wholly-owned subsidiary, LED Dental, has entered into a non-exclusive partnership with Benco Dental for the distribution of the company's VELscope Vx enhanced oral assessment system and product line within the US market.
LED Medical CEO Dr David Gane noted the company is pleased to partner with Benco for distribution in the US.
"Benco currently serves more than 35,000 customers across the country and maintains an excellent reputation in the dental industry. We are excited about the opportunity to work together, maximizing the significant sales potential for the VELscope Vx product line through its extensive network," Dr Gane added.
The distinctive blue-spectrum light of the VELscope Vx hand-held device causes the soft tissues of the mouth to naturally fluoresce.
Healthy tissues fluoresce in distinct patterns that are visibly disrupted by trauma or disease, such as neoplastic lesions, chemical irritation, side-effects from medication, thermal damage, fungal, viral or bacterial infections.
Use of the VELscope Vx allows a wide variety of oral abnormalities to be discovered, often before they're visible to the unassisted eye. It is also the only tissue fluorescence device with photo/video documentation capabilities through the viewing mechanism, a key function for referrals and patient records.
